How should I manage a patient with worsening depression and suicidal ideation?

Management of Worsening Depression with Suicidal Ideation

Immediately perform a comprehensive suicide risk assessment and offer cognitive behavioral therapy focused on suicide prevention, while considering ketamine infusion as adjunctive treatment for rapid reduction of suicidal ideation in patients with major depressive disorder. 1

Immediate Risk Assessment

Conduct a structured suicide risk evaluation that includes the following specific domains 1:

• Self-directed violence history: Past suicide attempts, current suicidal thoughts with plan/intent/means
• Current psychiatric status: Active depression severity, comorbid anxiety, substance use, psychotic symptoms
• Social determinants: Recent adverse life events (job loss, relationship breakdown, financial crisis), social isolation
• Lethal means access: Firearms, medications, other methods in the home
• Physical health: Chronic pain, terminal illness, recent medical diagnoses
• Demographics: Age, sex, prior psychiatric hospitalizations

Use validated screening tools 1:

• Columbia Suicide Severity Rating Scale Screener (preferred for general and high-risk populations)
• Patient Health Questionnaire-9 (PHQ-9)
• Beck Scale for Suicidal Ideation (for high-risk patients)

Critical caveat: While risk stratification is routine practice, no specific tool reliably predicts who will attempt suicide, so clinical judgment remains paramount 1.

Treatment Algorithm

First-Line Psychotherapy

Initiate cognitive behavioral therapy (CBT) focused specifically on suicide prevention 1. This is the only intervention with evidence for reducing suicide attempts in patients with recent suicidal behavior (within 6 months). CBT also reduces suicidal ideation independent of its effect on depression 2. Problem-solving therapy variants are also effective 1.

Important distinction: Standard depression-focused CBT may help, but suicide-specific CBT protocols directly target suicidal thoughts and behaviors as primary outcomes 2, 3.

Pharmacological Interventions

For Acute Suicidal Ideation with Major Depressive Disorder:

Consider ketamine infusion as adjunctive treatment 1, 4. The 2024 VA/DoD guidelines support ketamine for short-term (up to 7 days) reduction in suicidal ideation when added to ongoing antidepressant therapy. Esketamine (intranasal) is also an option but requires REMS certification and 2-hour post-treatment monitoring 4.

Key limitations:

• Evidence supports only short-term benefit (7 days for ketamine, up to 28 days for esketamine)
• No proven effect on preventing actual suicide attempts or deaths 1
• Reserved for patients who haven't responded to multiple antidepressant trials 4

For Underlying Depression:

Continue or optimize antidepressant therapy, but monitor closely during the first 10-14 days as suicide risk may transiently increase during this period 5. Consider short-term anxiolytics/hypnotics if severe anxiety or insomnia is present 5.

Special populations:

• Schizophrenia/schizoaffective disorder with suicidal ideation: Use clozapine, which reduces suicide attempts 1
• Bipolar disorder: Lithium has historical support for suicide prevention, though 2024 guidelines downgraded this to "insufficient evidence" 1

Interventions with Insufficient Evidence

Despite widespread clinical use, the following lack strong evidence 1:

• Safety planning interventions (neither for nor against)
• Crisis response plans (neither for nor against)
• Dialectical behavior therapy for suicidality (neither for nor against)
• Collaborative Assessment and Management of Suicidality/CAMS (neither for nor against)

Clinical reality: While evidence is insufficient, safety planning remains standard practice and causes no harm. Complete one pragmatically while prioritizing evidence-based CBT.

Ongoing Monitoring Strategy

Critical timing issue: Suicidal ideation can persist despite depression improvement 6. In one study, 25% of patients with depression remission still had persistent suicidal ideation, and 34% of treatment responders remained suicidal 6.

Monitoring protocol:

• Assess suicidal ideation separately from depression symptoms at each visit
• Continue close monitoring beyond initial weeks, even after antidepressant response 6
• Suicidal ideation predicts future depression worsening and chronic/recurrent depression 2, 7

Post-hospitalization: Send periodic caring communications (text, mail) for 12 months after any suicide-related hospitalization to reduce suicide attempt risk 1.

Disposition Decisions

Immediate psychiatric hospitalization if:

• Active plan with intent and access to means
• Recent suicide attempt
• Command hallucinations to self-harm
• Inability to contract for safety or engage in outpatient treatment

Urgent outpatient psychiatry referral (within 24-48 hours) if:

• Suicidal ideation without immediate plan/intent
• Adequate social support and safety planning possible
• Patient agrees to remove lethal means
• Reliable follow-up assured

Enhanced primary care management if:

• Passive suicidal ideation only
• Strong therapeutic alliance
• Access to crisis resources
• Frequent follow-up appointments possible (weekly initially)

Environmental Safety

Means restriction is essential 5:

• Remove firearms from home (most effective single intervention)
• Limit medication quantities to 7-day supplies
• Secure sharp objects, ropes, toxic substances
• Involve family in creating safe environment

Common pitfall: Clinicians often underestimate the importance of means restriction. This is one of the most evidence-based suicide prevention strategies but frequently neglected in practice 5.